Experienced in Pseudomyxoma Peritonei

Dieter Koeberle

St. Claraspital, 
Basel, BS, CH 
Experienced in Pseudomyxoma Peritonei
St. Claraspital, 
Basel, BS, CH 
OverviewLocationsClinical Research

Overview

Dieter Koeberle practices in Basel, Switzerland. Mr. Koeberle is rated as an Experienced expert by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Liver Cancer, Gastrointestinal Stromal Tumor, and Splenectomy.

His clinical research consists of co-authoring 53 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pseudomyxoma Peritonei.

Gender
Male

Locations

St. Claraspital, Basel, BS, Switzerland
Other Locations
Bern, BE 3010, Switzerland
Zurich, ZH, Switzerland
Kantonsspital
Sankt Gallen, SG, Switzerland
Luzern, LU, Switzerland
Cantonal Hospital St Gallen, St Gallen, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Enrollment Status: Terminated
Publish Date: May 16, 2025
Intervention Type: Drug
Study Drug: Aspirin
Study Phase: Phase 3
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks - A Non-Inferiority Phase III Trial
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks - A Non-Inferiority Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drug: Denosumab
Study Phase: Phase 3
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer. A Multicenter Phase Ib Trial (RECAP)
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer. A Multicenter Phase Ib Trial (RECAP)
Enrollment Status: Terminated
Publish Date: January 10, 2023
Intervention Type: Drug, Radiation, Procedure
Study Phase: Phase 1
View 2 Less Clinical Trials

53 Total Publications

Guidelines of Onkopedia: What Is New?
Guidelines of Onkopedia: What Is New?
Journal: Oncology research and treatment
Published: April 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Koeberle's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile